| Value | ₹50.00 Cr |
|---|
NSE filing, NSE: SMSPHARMA. Summary written from the filing by ALFA Finder's alert engine.
SMS Pharmaceuticals Ltd: key numbers
- Share price
- ₹511.35
- Market cap
- ₹4,533 Cr
- Revenue (annual)
- ₹886.9 Cr
- Net profit (annual)
- ₹102.0 Cr
- P/E (TTM)
- 44.3×Sector 48.7×
- Promoter holding
- 68.07%+0.00% QoQ
- FII holding
- 1.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SMS Pharmaceuticals Ltd
All →SMS Pharmaceuticals Board Meeting Date
SMS Pharmaceuticals has scheduled a board meeting for November 4, 2026, to consider Q2 FY27 unaudited results. This is a routine advance intimation.
SMS Pharmaceuticals Other Announcement
SMS Pharmaceuticals Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance filing.
SMS Pharmaceuticals Annual General Meeting
SMS Pharmaceuticals Limited held its 38th Annual General Meeting on September 29, 2026. Shareholders transacted business including the adoption of financial statements and declaration of dividend.
SMS Pharmaceuticals Other Announcement
SMS Pharmaceuticals disclosed two market sell trades by Designated Person NVV Satyanarayana totalling ₹0.14 Crore. The PIT Reg 7(2) intimation involves a non-promoter designated person.
- Value
- ₹0.14 Cr
SMS Pharmaceuticals Annual General Meeting
SMS Pharmaceuticals Limited has scheduled its 38th Annual General Meeting for September 29, 2026. Key agenda items include dividend declaration, management re-appointments, and approval of material related party transactions.
SMS Pharmaceuticals Annual Report
SMS Pharmaceuticals Limited has released its Annual Report and Notice for the 38th Annual General Meeting scheduled for September 29, 2026. The company reported FY26 revenue of ₹887 Crore.
Other debt & borrowing announcements
All →Union Bank of India Debt & Borrowing: ₹3,500 Cr
Union Bank of India exercised call options on Tier-1 bond series XXXII and XXXIII. Redemption payments fall on November 21 and December 19, 2026, aggregating Rs.3,500 Crore.
- Value
- ₹3,500 Cr
EPL Debt & Borrowing
EPL certified CP proceeds for the quarter ended September 30, 2026 were used as disclosed. It is a periodic debt-listing compliance certificate, with no new money raised.
Tinna Rubber and Infrastructure Debt & Borrowing: ₹0.95 Cr
Tinna Rubber remitted the third tranche of a US$1,00,000 (INR 95.10 lakh) loan to its South African joint venture Mbodla Investments. This continues the August 2026 loan programme disclosure.
- Value
- ₹0.95 Cr
Poonawalla Fincorp Debt & Borrowing: ₹12.35 Cr
Poonawalla Fincorp paid Rs.12.35 Crore interest on its Rs.500 Crore NCDs (ISIN INE511C07AB9) on time, 30 October 2026. The payment was made under Regulation 57 with no delay.
- Value
- ₹12.35 Cr
Antony Waste Handling Cell Debt & Borrowing: ₹5.04 Cr
Antony Waste Handling Cell issued a Rs.5.04 Crore corporate guarantee to Kotak Mahindra Bank for Mumbai Eco. It is a contingent liability on Mumbai Eco's repayment.
- Value
- ₹5.04 Cr
Antony Waste Handling Cell Debt & Borrowing: ₹9.89 Cr
Antony Waste Handling issued a Rs 9.89 Crore corporate guarantee to Kotak Mahindra Bank for subsidiary Mumbai Eco Solutions. The guarantee is a contingent liability for the company.
- Value
- ₹9.89 Cr